"compound 72"
oral PRMT5 inh. for treating cancers projected human dose of 15 mg QD w/ 6 HBD SBDD from SAM cofactor J. Med. Chem., Mar. 23, 2021 Merck & Co, Boston, MA
Molecules of the Month - March 2021
Molecules of the Month
- LSN3318839
- GLPG1972
- APJ compound 14
- encequidar
- S62798 (Servier)
- CVN424
- ABBV-167
- GDC-0310
- "compound 72"
- "compound 20"
- TAK-418
- compound 13 (GSK716)
- RBN-012759
- sisunatovir